Recap: AbCellera Biologics Q4 Earnings

AbCellera Biologics (NASDAQ:ABCL) reported its Q4 earnings results on Tuesday, February 20, 2024 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

AbCellera Biologics missed estimated earnings by 30.77%, reporting an EPS of $-0.17 versus an …

Full story available on Benzinga.com